SEARCH

SEARCH BY CITATION

References

  • 1
    Cummings JL. Epilepsy: ictal and interictal behavioural alterations. Clin Neuropsychiatry 1985;111:95117.
  • 2
    Pond DA. Psychiatric aspects of epilepsy. J Indian Med Prof 1957;3:14411451.
  • 3
    Blumer D. The psychiatric disorders of epilepsy: recognition and treatment. Course 29, Psychiatric disorders related to epilepsy. APA 151st annual meeting, 30 May – 4 June, Toronto (5–30–4), 1999.
  • 4
    American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: APA, 1994.
  • 5
    Blumer D, Herzog AG, Himmelhoch J, Salgueiro CA, Ling FW. To what extent do premenstrual and interictal dysphoric disorder overlap? Significance for therapy. J Affect Disord 1998;48:215225.
  • 6
    Dimmock PW, Wyatt KM, Jones PW, O'Brien S. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000;356:11311136.
  • 7
    Mendez MF, Cummings JL, Benson DF. Depression in epilepsy. Significance and phenomenology. Arch Neurol 1986;43:766770.
  • 8
    Schmitz EB, Robertson MM, Trimble MR. Depression and schizophrenia in epilepsy: social and biological risk factors. Epilepsy Res 1999;35:5968.
  • 9
    Hermann BP, Seidenberg M, Bell B. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 2000;41 (Suppl. 2):S31S41.
  • 10
    Mendez MF, Taylor JL, Doss RC, Salguero P. Depression in secondary epilepsy: relation to lesion laterality. J Neurol Neurosurg Psychiatry 1994;57:232233.
  • 11
    Anhoury S, Brown RJ, Chrisnamoorthy ES, Trimble M. Psychiatric outcome after temporal lobectomy: a predictive study. Epilepsia 2000;41:16081615.
  • 12
    Altshuler LL, Devinsky O, Post RM, Theodore W. Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms. Arch Neurol 1990;47:284288.
  • 13
    Strauss E, Wada J, Moll A. Depression in male and female subjects with complex partial seizures. Arch Neurol 1992;49:391392.
  • 14
    Schmitz EB, Moriarty J, Costa DC, Ring HA, Ell PJ, Trimble MR. Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy. J Neurol Neurosurg Psychiatry 1997;62:458463.
  • 15
    Mendez MF, Doss RC, Taylor JL, Salguero P. Depression in epilepsy. Relationship to seizures and anticonvulsant therapy. J Nerv Ment Dis 1993;181:444447.
  • 16
    Carrieri PB, Provitera V, Iacovitti B et al. Mood disorders in epilepsy. Acta Neurol 1993;15:6267.
  • 17
    Trimble MR. New anti-epileptic drugs and psychopathology. Neuropsychobiology 1998;38:149151.
  • 18
    Trimble MR, Rusch N, Betts T, Crawford PM. Psychiatric symptoms after therapy with new anti-epileptic drugs: psychopathological and seizure related variables. Seizure 2000;9:249254.DOI: 10.1053/seiz.2000.0405
  • 19
    Koponen H, Honkonen S, Partanen J, Riekkinen PJ. Epileptic attack, delirium, and periodic complexes in the EEG during mianserin treatment. J Neurol Neurosurg Psychiatry 1991;54:379.
  • 20
    Curran S, De Pauw K. Selecting an antidepressant for use in a patient with epilepsy. Safety considerations. Drug Safety 1998;18:125133.
  • 21
    Darley J. Interaction between phenytoin and fluoxetine. Seizure 1994;3:151152.
  • 22
    Selai CE, Smith K, Trimble MR. Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs. Seizure 1999;8:8133.
  • 23
    Blumer D. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. J Clin Psychiatry 1997;58:311.
  • 24
    Mulrow CD, Williams JW Jr., Chiquette E et al. Evidence report/technology assessment no. 7. Treatment of depression: newer pharmacotherapies. AHCPR publication no. 99-E014. Rockville, MD: Agency for Health Care Policy and Research, US Department of Health and Human Services, 1999.
  • 25
    Wolf P. Manic episodes in epilepsy. In: AkimotoH, KazamatsuriH, SeinoM, WardA, eds. Advances in epileptology. XIIIth Epilepsy International Symposium. New York: Raven Press, 1982.
  • 26
    Robertson MM. Affect and mood in epilepsy: an overview with a focus on depression. Acta Neurol Scand 1992;140 (Suppl.):127132.
  • 27
    Sachs GS, Printz DJ, Kahn DA, Carpener D, Docherty JP. The expert consensus guideline series. Medication treatment of bipolar disorder. Postgraduate Medicine Special Report: McGrawHill Healthcare Information Programs, New York, US, 2000.
  • 28
    Sheard MH. Clinical pharmacology of aggressive behaviour. Clin Neuropharmacol 1984;7:173183.
  • 29
    Post RM, Denicoff KD, Frye MA et al. A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century. Neuropsychobiology 1998;38:152166.
  • 30
    Nolen WA, Kupka RW. The efficacy of valproate, lamotrigine and gabapentin in bipolar disorder: review of double-blind controlled studies. Acta Neuropsychiatr 2000;12:122127.
  • 31
    Van der Feltz-Cornelis CM, Lyons JS, Huyse FJ et al. Health services research on mental health in primary care. Int J Psychiatr Med 1997;27:121.
  • 32
    Manchanda R, Schaefer B, McLachlan RS et al. Psychiatric disorders in candidates for surgery for epilepsy. J Neurol Neurosurg Psychiatry 1996;61:8289.
  • 33
    Spitz MC. Panic disorder in seizure patients: a diagnostic pitfall. Epilepsia 1991;32:3338.
  • 34
    Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am 1997;20:427451.